Evidence that failure to conceive despite apparent correction of ovulatory defects by follicle-maturing drugs may be related to premature trophoblast invasion

Medical Hypotheses

Volumn 59, Issue 4, 2002, Pages 385-388

  Check, J H ^a   Check, M L ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CLOMIFENE; ESTROGEN; GONADOTROPIN; METFORMIN; PROGESTERONE; PROGESTERONE INDUCED BLOCKING FACTOR; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

CELL INVASION; CONCEPTION; EMBRYO TRANSFER; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GESTATION PERIOD; HUMAN; INTERMETHOD COMPARISON; MEDICAL RESEARCH; NIDATION; OVARY FOLLICLE MATURATION; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVIEW; TREATMENT FAILURE; TROPHOBLAST; UTERUS;

EID: 0036784419     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(02)00126-3     Document Type: Article

References (34)

1. An evaluation of etiologic factors and therapy in 555 private patients with primary infertility
2. The efficacy of progesterone in achieving successful pregnancy: I. Prophylactic use during luteal phase in anovulatory women
3. Luteinized unruptured follicle syndrome: A subtle cause of infertility
4. Delayed onset of luteinization as a cause of infertility
5. Follicle growth curves and hormonal patterns in patients with the luteinized unruptured follicle syndrome
6. Incidence, recurrence and treatment of the luteinized unruptured follicle syndrome
7. New approaches to the diagnosis and therapy of the luteinized unruptured follicle syndrome
8. Comparison of various therapies for the luteinized unruptured follicle syndrome
9. Pelvic sonography can predict ovum release in gonadotrophin-treated patients as determined by pregnancy rate
10. The efficacy of short-term gonadotrophin-releasing hormone agonists versus human chorionic gonadotrophin to enable oocyte release in gonadotrophin stimulated cycles
11. Preliminary report about a modified gonadotropin (human menopausal gonadotropin/human chorionic gonadotropin). Treatment in infertile patients with premature luteinization
12. Successful treatment of infertile women with oligomenorrhea using a combination of LHRH agonist and exogenous gonadotrophins
13. Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression
14. Premature luteinization: Treatment and incidence in natural cycles
15. Antiestrogenic effect of clomiphene in the human being
16. A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test
17. Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation
18. Antiestrogenic effect of clomiphene citrate: Correlation with serum estradiol concentrations
19. Effect of clomiphene citrate therapy on postcoital tests in successive treatment cycles including response to supplemental estrogen therapy
20. Ovarian hyperstimulation can reduce uterine receptivity. A case report
21. Embryo implantation after human in vitro fertilization: Importance of endometrial receptivity
22. Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients
23. Evaluation of the mechanism for higher pregnancy rates in donor oocyte recipients by comparison of fresh with frozen embryo transfer pregnancy rates in a shared oocyte programme
24. Controlled ovarian hyperstimulation adversely affect implantation following in vitro fertilization-embryo transfer
25. Comparable implantation rates with fresh vs frozen embryo transfer suggests that controlled ovarian hyperstimulation has an adverse effect on conception outcome
26. A case report demonstrating that follicle maturing drugs may create an adverse uterine environment even when not used for controlled ovarian hyperstimulation
27. Ovulation-inducing drugs versus progesterone therapy for infertility in patients with luteal phase defects
28. The mechanism of the inhibitory effect of progesterone on lymphocyte cytotoxicity: I. Progesterone-treated lymphocytes release a substance inhibiting cytotoxicity and prostaglandin synthesis
29. The role of gamma/delta T cells in progesterone-mediated immunomodulation during pregnancy: A review
30. Progesterone receptors in lymphocytes of liver-transplanted and transfused patients
31. Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody
32. Progesterone induced blocking factor seen in pregnancy lymphocytes soon after implantation